Plus Therapeutics
PSTV
PSTV
17 hedge funds and large institutions have $4.53M invested in Plus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $6.25M → $4.53M (-$1.72M)
39% less call options, than puts
Call options by funds: $33K | Put options by funds: $54K
Holders
17
Holding in Top 10
–
Calls
$33K
Puts
$54K
Top Buyers
| 1 | +$56K | |
| 2 | +$34.1K | |
| 3 | +$27K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$22.3K |
| 5 |
Renaissance Technologies
New York
|
+$15K |
Top Sellers
| 1 | -$170K | |
| 2 | -$80.2K | |
| 3 | -$58K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$15K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$7K |